London · Delayed Price · Currency is GBP · Price in GBX Oxford BioDynamics Company Description
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom.
The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy.
EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker.
Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points.
The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
| Country | United Kingdom |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 41 |
| CEO | Jon Anthony Burrows |
Contact Details
Address: 3140 Rowan Place Oxford, OX4 2WB United Kingdom | |
| Phone | 44 1865 518 910 |
| Website | oxfordbiodynamics.com |
Stock Details
| Ticker Symbol | OBD |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | October - September |
| Reporting Currency | GBP |
| ISIN Number | GB00BD5H8572 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Jon Anthony Burrows | Chief Executive Officer |
| Paul Stockdale | Chief Financial Officer |
| Thomas Guiel | Chief Operating Officer |